26 Pulmonary Embolism Clinical Trials in Minneapolis, MN (2026)

Q: How do I join a clinical trial in Minneapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you.

Recruiting Pulmonary Embolism Studies in Minneapolis

NCT00097292Recruiting

TrialNet Pathway to Prevention of T1D

Rationale: The accrual of data from the laboratory and from epidemiologic and prevention trials has improved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Gen...

Minneapolis, MN75,000 participantsUniversity of South Florida

View Study Details

NCT03141021Recruiting

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor (MPNST) and precursor le...

Minneapolis, MN1,050 participantsWashington University School of Medicine

View Study Details

NCT06820736Recruiting

A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion

This project is being done to understand if a drain reduces recovery problems after surgery, such as infection or the need for more surgery....

Minneapolis, MNNA975 participantsTwin Cities Spine Center

View Study Details

NCT06994442Recruiting

Optimizing Pain Treatment in Children On Mechanical Ventilation

In this clinical trial, investigators want to learn more about using non-opioid pain medications for children with acute respiratory failure. Right now, doctors give these children opioids to help wit...

Minneapolis, MNPHASE3644 participantsWeill Medical College of Cornell University

View Study Details

NCT07146516Recruiting

Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)

The goal of this clinical trial is to prospectively document to what extent the OSC/SS prophylactic laser retinopexy procedure works to prevent retinal detachment in SS in children and adults. Resear...

Minneapolis, MNNA500 participantsHelen Keller Eye Research Foundation

View Study Details

NCT03922724Recruiting

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Background: Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the complications transplant can cause. Objective:...

Minneapolis, MNPHASE2330 participantsNational Cancer Institute (NCI)

View Study Details

NCT06527391Recruiting

Choline and Iron Deficiency

BACKGROUND: Iron deficiency limits the neurodevelopmental potential of more than 200 million children each year. Iron therapy is typically started when iron deficiency anemia is first diagnosed after...

Minneapolis, MNPHASE2300 participantsUniversity of Minnesota

View Study Details

NCT07091487Recruiting

Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management

The goal of this clinical trial is to learn if the Diabetes Homelessness Medication Support (D-HOMES) wellness coaching model is effective for adults who speak English or Spanish, have Type 2 diabetes...

Minneapolis, MNNA256 participantsKatherine Vickery

View Study Details

NCT04228978Recruiting

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

The PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline in six-minute walk dis...

Minneapolis, MNNA212 participantsNorthwestern University

View Study Details

NCT06032065Recruiting

SMART Exercise for PAD

Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lowe...

Minneapolis, MNPHASE3210 participantsNorthwestern University

View Study Details

NCT06712823Recruiting

An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of atumelnant (CRN04894)....

Minneapolis, MNPHASE2200 participantsCrinetics Pharmaceuticals Inc.

View Study Details

NCT04794530Recruiting

The COCOA-PAD II Trial

Among people with peripheral artery disease (PAD) age 55 and older, the investigators will test the hypothesis that PAD participants randomized to cocoa flavanols will have greater improvement or less...

Minneapolis, MNPHASE3190 participantsNorthwestern University

View Study Details

NCT07541573Recruiting

GTB-5550 in Advanced Solid Tumors

This is a first-in-human Phase 1a/1b trial of a B7-H3-targeted natural killer (NK) cell engager, referred to as a TriSpecific Killer Engager (TriKE), for the treatment of select solid tumor cancers. T...

Minneapolis, MNPHASE1175 participantsMasonic Cancer Center, University of Minnesota

View Study Details

NCT07109739Recruiting

Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function

This study will assess the dose-response effects of Inspiratory Muscle Strength Training (IMST) in adults with above-normal systolic blood pressure over a 6-week period....

Minneapolis, MNNA144 participantsUniversity of Minnesota

View Study Details

NCT07061574Recruiting

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in person...

Minneapolis, MNPHASE1120 participantsCity of Hope Medical Center

View Study Details

NCT07520838Recruiting

Improving Barriers to Care Access for Children With Autism and Related Needs Via Telehealth for Evaluation, Care Navigating, and Caregiver Coaching

The objectives of the current project are to develop and implement training with community providers to evaluate a supplemental parent coaching intervention delivered via telehealth to improve child c...

Minneapolis, MNNA90 participantsUniversity of Minnesota

View Study Details

NCT06507657Recruiting

Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce CVD events, including incident HF. SGLT2 is a glucose transport protein in the kidneys. Inhibition of this protein results in glucosuria and l...

Minneapolis, MNEARLY_PHASE180 participantsUniversity of Minnesota

View Study Details

NCT05456321Recruiting

CIFASD 5 tDCS and Cognitive Training

This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure ...

Minneapolis, MNNA70 participantsUniversity of Minnesota

View Study Details

NCT07005050Recruiting

Renal Pelvic Denervation Pilot Trial

The RPD Pilot trial will evaluate the safety and effectiveness of Verve Medical's RPDTM renal denervation system for hypertensive patients with uncontrolled blood pressure despite use of two medicatio...

Minneapolis, MNNA60 participantsVerve Medical, Inc

View Study Details

NCT07223944Recruiting

A Gaucher Disease Gene Therapy Trial With FLT201

This study is a Phase 3, non-randomized, multicenter, efficacy and safety study in adult patients with Gaucher disease Type 1, on stable treatment with enzyme replacement therapy (ERT) or substrate re...

Minneapolis, MNPHASE345 participantsSpur Therapeutics

View Study Details

NCT06747611Recruiting

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

Alopecia Areata (AA) is among the most highly prevalent human autoimmune diseases, leading to disfiguring hair loss due to the collapse of immune privilege of the hair follicle and subsequent autoimmu...

Minneapolis, MNPHASE240 participantsUniversity of Minnesota

View Study Details

NCT04555161Recruiting

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right hea...

Minneapolis, MNNA30 participantsAria CV, Inc

View Study Details

NCT07246993Recruiting

Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms

This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as a novel treatment approach aimed at impro...

Minneapolis, MNNA30 participantsUniversity of Minnesota

View Study Details

NCT06831058Recruiting

A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Immune-mediated Thrombotic thrombocytopenic purpura (iTTP) is a rare, autoimmune disorder characterized by life-threatening episodes of thrombocytopenia, microangiopathic hemolytic anemia and organ da...

Minneapolis, MNPHASE215 participantsUniversity of Minnesota

View Study Details

NCT06693284Recruiting

A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]

This is a single center Phase 0 "window of opportunity" trial for the treatment of newly diagnosed, PRC2 deficient, primary malignant peripheral nerve sheath tumors (MPNSTs) with a short course of the...

Minneapolis, MNEARLY_PHASE18 participantsUniversity of Minnesota

View Study Details

NCT05586243Recruiting

MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)

Recent studies have has shown that magnetic resonance spectroscopy (MRS) can provide validated neuronal markers in patients with Type 1 GD (GD1) who are on stable therapy. However, alterations in neur...

Minneapolis, MN5 participantsUniversity of Minnesota

View Study Details

About Pulmonary Embolism Clinical Trials in Minneapolis

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 26 pulmonary embolism clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 80,779 participants. Research is being sponsored by University of South Florida, Washington University School of Medicine, Twin Cities Spine Center and 12 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Minneapolis — FAQ

Are there pulmonary embolism clinical trials in Minneapolis?

Yes, there are 26 pulmonary embolism clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 26 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 18, 2026 from ClinicalTrials.gov